LV11630A - T sunu antigena receptora V apgabala pilna garuma olbaltumvielas - Google Patents

T sunu antigena receptora V apgabala pilna garuma olbaltumvielas

Info

Publication number
LV11630A
LV11630A LV960313A LV960313A LV11630A LV 11630 A LV11630 A LV 11630A LV 960313 A LV960313 A LV 960313A LV 960313 A LV960313 A LV 960313A LV 11630 A LV11630 A LV 11630A
Authority
LV
Latvia
Prior art keywords
full length
antigen receptor
length proteins
region full
dog antigen
Prior art date
Application number
LV960313A
Other languages
English (en)
Other versions
LV11630B (en
Inventor
Savvas C Makrides
Patrick C Kung
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of LV11630A publication Critical patent/LV11630A/lv
Publication of LV11630B publication Critical patent/LV11630B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
LVP-96-313A 1994-01-13 1996-07-23 T cell antigen receptor v region proteins and methods of preparation thereof LV11630B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/181,492 US5552300A (en) 1994-01-13 1994-01-13 T cell antigen receptor V region proteins and methods of preparation thereof
PCT/US1995/000408 WO1995019435A2 (en) 1994-01-13 1995-01-12 T cell antigen receptor v region proteins and methods of preparation thereof

Publications (2)

Publication Number Publication Date
LV11630A true LV11630A (lv) 1996-12-20
LV11630B LV11630B (en) 1997-08-20

Family

ID=22664497

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-96-313A LV11630B (en) 1994-01-13 1996-07-23 T cell antigen receptor v region proteins and methods of preparation thereof

Country Status (21)

Country Link
US (1) US5552300A (lv)
EP (1) EP0738322A1 (lv)
JP (1) JPH10501961A (lv)
KR (1) KR100213396B1 (lv)
AU (1) AU700661B2 (lv)
BR (1) BR9506612A (lv)
CA (1) CA2181171A1 (lv)
CZ (1) CZ9602009A3 (lv)
EE (1) EE03287B1 (lv)
FI (1) FI962844A (lv)
HU (1) HUT75551A (lv)
IL (1) IL112316A0 (lv)
LV (1) LV11630B (lv)
MX (1) MX9602750A (lv)
NO (1) NO962921L (lv)
NZ (2) NZ279605A (lv)
PL (1) PL181072B1 (lv)
SG (1) SG52342A1 (lv)
SK (1) SK90696A3 (lv)
WO (1) WO1995019435A2 (lv)
ZA (1) ZA95261B (lv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113903A (en) * 1989-03-21 2000-09-05 The Immune Response Corporation Peptides and methods against diabetes
US20030109680A1 (en) * 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US7749498B2 (en) * 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) * 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20040229282A1 (en) * 1997-03-10 2004-11-18 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
JP4932086B2 (ja) 1999-04-08 2012-05-16 インターセル ユーエスエイ、インコーポレイテッド 経皮的免疫のための乾燥製剤
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20030190705A1 (en) * 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
BRPI0305769A8 (pt) * 2002-08-08 2017-09-12 Baylor College Medicine Isolamento e identificação de células t
CN1863556B (zh) * 2003-06-19 2012-05-16 吉宁特有限公司 用于治疗凝血相关紊乱的组合物和方法
JP2008505685A (ja) * 2004-07-06 2008-02-28 トランスファーマ メディカル リミテッド 経皮免疫処置用送達システム
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
US20070009542A1 (en) 2005-07-05 2007-01-11 Galit Levin Method and device for transdermal immunization
CN101242869B (zh) 2005-09-02 2010-05-26 Iomai公司 经皮递送疫苗和透皮递送药物的装置及其应用
ES2553192T3 (es) * 2006-05-05 2015-12-04 Opexa Therapeutics Vacuna de células T
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
US9181527B2 (en) 2009-10-29 2015-11-10 The Trustees Of Dartmouth College T cell receptor-deficient T cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US9833476B2 (en) 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
WO2013169691A1 (en) 2012-05-07 2013-11-14 Trustees Of Dartmouth College Anti-b7-h6 antibody, fusion proteins, and methods of using the same
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713332A (en) * 1984-01-13 1987-12-15 The Ontario Cancer Institute T cell specific CDNA clone
US4873190A (en) * 1984-06-13 1989-10-10 Massachusetts Institute Of Technology Heterodimeric T lymphocyte receptor
DE3588219T2 (de) * 1984-03-01 2000-05-18 Univ Leland Stanford Junior T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5260223A (en) * 1986-07-03 1993-11-09 President & Fellows Of Harvard College Methods for detection of human gamma, γ T cell receptor
US5340921A (en) * 1986-07-03 1994-08-23 T Cell Sciences, Inc. Γ, δT cell receptor and methods and detection
US5024940A (en) * 1987-02-19 1991-06-18 T Cell Sciences, Inc. Nucleic acids encoding the delta chain of the T cell antigen receptor
US5185250A (en) * 1986-07-03 1993-02-09 T Cell Sciences, Inc. Human γ, δT cell antigen receptor polypeptides and nucleic acids
DE3855634T2 (de) * 1987-06-23 1997-02-27 Univ Leland Stanford Junior Innerhalb des alpha-Locus gelegenes T-Zell-Rezeptor-Gen und DNA-Konstruktionen
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
CA2046909A1 (en) * 1989-03-21 1990-09-22 Mark D. Howell Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
CA2032138A1 (en) * 1989-05-02 1990-11-03 Irun R. Cohen Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
AU653527B2 (en) * 1990-05-01 1994-10-06 Board Of Trustees Of The Leland Stanford Junior University T-cell receptor variable transcripts as disease related markers
ES2098368T3 (es) * 1990-08-09 1997-05-01 Nat Jewish Ct Immun & Respirat Produccion de anticuerpos monoclonales contra un elemento vbeta humano de los receptores de las celulas t, utilizando vectores de adn recombinante.
EP0528007A1 (fr) * 1991-02-12 1993-02-24 Roussel Uclaf SEQUENCES NUCLEOTIDIQUES CODANT POUR DES REGIONS VARIABLES DE CHAINES $g(b) DES RECEPTEURS DES LYMPHOCYTES T HUMAINS, SEGMENTS PEPTIDIQUES CORRESPONDANTS ET LES APPLICATIONS DIAGNOSTIQUES ET THERAPEUTIQUES
EP0587735B1 (en) * 1991-05-31 2000-01-26 Connetics Corporation T cell receptor peptides as therapeutics for immune-related disease
JPH06511241A (ja) * 1991-09-23 1994-12-15 ジェネンテク，インコーポレイテッド 自己免疫疾患の診断および治療
US5333487A (en) * 1991-11-15 1994-08-02 Hughes Aircraft Company Spark-excited fluorescence sensor
US5212091A (en) * 1992-03-02 1993-05-18 Monsanto Company Method of producing tissue factor pathway inhibitor

Also Published As

Publication number Publication date
KR970700772A (ko) 1997-02-12
HUT75551A (en) 1997-05-28
NZ332715A (en) 2000-06-23
NO962921L (no) 1996-09-02
FI962844A (fi) 1996-08-29
WO1995019435A2 (en) 1995-07-20
PL181072B1 (pl) 2001-05-31
US5552300A (en) 1996-09-03
FI962844A0 (fi) 1996-07-12
JPH10501961A (ja) 1998-02-24
WO1995019435A3 (en) 1995-08-24
MX9602750A (es) 1997-05-31
HU9601908D0 (en) 1996-09-30
NO962921D0 (no) 1996-07-11
NZ279605A (en) 1999-01-28
IL112316A0 (en) 1995-03-30
SK90696A3 (en) 1997-07-09
AU1678495A (en) 1995-08-01
PL319374A1 (en) 1997-08-04
ZA95261B (en) 1995-11-14
EP0738322A1 (en) 1996-10-23
AU700661B2 (en) 1999-01-14
KR100213396B1 (ko) 1999-08-02
LV11630B (en) 1997-08-20
CA2181171A1 (en) 1995-07-20
SG52342A1 (en) 1999-06-22
CZ9602009A3 (en) 1997-12-17
BR9506612A (pt) 1997-09-16
EE03287B1 (et) 2000-08-15

Similar Documents

Publication Publication Date Title
LV11630A (lv) T sunu antigena receptora V apgabala pilna garuma olbaltumvielas
CY2005008I1 (el) Αντισωματα αντι - vegf
DE69232604D1 (de) Antikörperkonstrukte
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
NO980915L (no) Rekombinante anti-CD4-antistoff egnet for human terapi
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
FI20115005A (fi) Melanooma-antigeeni
NO985464D0 (no) Konsentrert antistoffpreparat
FI964235A (fi) Melanooma-antigeeni
IS5375A (is) KAY-nýstárlegt ónæmisprótín
DK0876482T3 (da) IL-13-receptorpolypeptid
FI970633A0 (fi) Glutamaattireseptori
DK0779035T3 (da) Modificeret valleprotein
NO976058L (no) Rekombinant mistellectin
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
DE69738312D1 (de) Hepatitis b monoklonale antikörper
FI972763A0 (fi) Mutanttiproteiineja
BR9706358A (pt) Protéinas anti-obesidade
DE69522911T2 (de) Migrationsabbildungselement
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
EP0984065A4 (en) MODIFIED PROTEINANTIGENT FROM TREPONEMA PALLADIUM.
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
BR9510060A (pt) Receptor
DE29512719U1 (de) Monoklonale Antikörper gegen humanes Interleukin-10
DK0919617T3 (da) Monoklonale antistoffer mod humant MP52